For instance, it has been reported that the overexpression of miR-21 negatively regulates RECK gene expression in glioma [38,39], nerve injury [40], osteosarcoma [41], esophageal squamous cell carcinoma [42], and colon cancer [43]. This evidence concerns the gene RECK and central nervous system cancer.